AgelessRx vs Joey Med
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AgelessRx
Best for longevity-focused GLP-1 care (pending verification)Starting at $199/mo
Joey Med
Best for Cost-sensitive buyers in the broader DTC market who want a single-platform option for weight-loss GLP-1 plus sexual health, longevity, hair, and travel wellness add-ons, who are comfortable with limited drug-name and pharmacy-partner transparency at sign-up.Starting at $199/mo
Side-by-Side Comparison
| Feature | AgelessRx | Joey Med |
|---|---|---|
| Overall Score | ✓7.1/10 | 5.6/10 |
| Starting Price | $199/mo | $199/mo |
| Editorial Rating | ✓3.6 ★ /5 | 2.8 ★ /5 |
| Features | 6 features | ✓10 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
AgelessRx
Pros
- ✓Established brand based in Ann Arbor, MI with US-licensed providers
- ✓Offers both compounded and brand-name (Wegovy) options
- ✓Longevity-first positioning — patients get a broader metabolic health framing vs single-condition GLP-1 funnels
- ✓Listed in both competitor directories
Cons
- ✗Stub entry — pricing, states served, and GLP-1-specific intake workflow need YMYL verification
- ✗Confidence LOW until verified
- ✗Longevity-first positioning means GLP-1 is one of several products — patients looking specifically for GLP-1 care may be funneled into a broader longevity intake
Joey Med
Pros
- ✓Tier pricing transparency — three GLP-1 product tiers listed with dual-pricing (likely promotional / standard structure) on the products page
- ✓All-50-states shipping coverage with explicit 'medications shipped to all 50 states' framing
- ✓Refund policy is publicly linked (text not extracted, but acknowledged at /refund-cancellation)
- ✓Tampa, FL location anchor — provides at least a geographic identifier
- ✓Multi-vertical DTC model lets patients consolidate weight loss with other men's-health-adjacent treatments (ED, hair, longevity)
Cons
- ✗Specific drug names (semaglutide vs tirzepatide) NOT explicitly disclosed on product page — products marketed as 'GLP-1 Core' / 'GLP-1 Plus Core' / 'GLP-1 Plus Core High Dose' without confirming the active ingredient per tier
- ✗Compounded vs brand-name designation NOT explicitly disclosed (inferred as compounded based on pricing + dose-tiering structure but should be verified)
- ✗503A vs 503B compounding designation NOT specified
- ✗Pharmacy partner NOT named — no address or name disclosed
- ✗LegitScript certification NOT mentioned on the homepage
- ✗FDA compounded-medication disclaimer NOT published on the homepage
- ✗Named medical director / clinical leadership NOT disclosed
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed (only '© 2026 Joey Med' copyright)
- ✗Governing law / arbitration venue NOT disclosed
- ✗Dual-pricing structure ($279/$199, $399/$275, $599/$399) is ambiguous — not clear whether promotional, intro-month-only, or refill-vs-standard
- ✗Generic product naming ('GLP-1 Core/Plus/High Dose') reduces transparency vs explicit-drug-name competitors
Our Verdict
AgelessRx edges out Joey Med with a higher overall score of 7.1/10 and is particularly strong for longevity-focused GLP-1 care (pending verification). Joey Med remains a solid alternative, especially if you're looking for Cost-sensitive buyers in the broader DTC market who want a single-platform option for weight-loss GLP-1 plus sexual health, longevity, hair, and travel wellness add-ons, who are comfortable with limited drug-name and pharmacy-partner transparency at sign-up..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.